438 related articles for article (PubMed ID: 30660629)
21. Manufacturing of Dexamethasone-Poly(d,l-Lactide-co-Glycolide) Implants Using Hot-Melt Extrusion: Within- and Between-Batch Product Performance Comparisons.
Kelley RA; Ghaffari A; Wang Y; Choi S; Taylor JR; Hartman RR; Kompella UB
J Ocul Pharmacol Ther; 2020 Jun; 36(5):290-297. PubMed ID: 32330403
[No Abstract] [Full Text] [Related]
22. Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone.
Barcia E; Herrero-Vanrell R; Díez A; Alvarez-Santiago C; López I; Calonge M
Exp Eye Res; 2009 Aug; 89(2):238-45. PubMed ID: 19341729
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.
Sakai T; Ishihara T; Higaki M; Akiyama G; Tsuneoka H
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1516-21. PubMed ID: 21178146
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal thalidomide ameliorates inflammation in a model of experimental uveitis induced by BCG.
Castro BFM; Vieira LC; Vasconcelos-Santos DV; Cenachi SPF; Cotta OAL; Guerra MCA; Paiva MRB; Silva LM; Silva-Cunha A; Fialho SL
Int Immunopharmacol; 2020 Apr; 81():106129. PubMed ID: 32018067
[TBL] [Abstract][Full Text] [Related]
25. Novel Dexamethasone Sodium Phosphate Treatment (DSP-Visulex) for Noninfectious Anterior Uveitis: A Randomized Phase I/II Clinical Trial.
Papangkorn K; Truett KR; Vitale AT; Jhaveri C; Scales DK; Foster CS; Montieth A; Higuchi JW; Brar B; Higuchi WI
Curr Eye Res; 2019 Feb; 44(2):185-193. PubMed ID: 30354530
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.
He Y; Wang JC; Liu YL; Ma ZZ; Zhu XA; Zhang Q
J Ocul Pharmacol Ther; 2006 Apr; 22(2):121-31. PubMed ID: 16722798
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis.
Bratton ML; He YG; Weakley DR
J AAPOS; 2014 Apr; 18(2):110-3. PubMed ID: 24698604
[TBL] [Abstract][Full Text] [Related]
28. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
Daull P; Paterson CA; Kuppermann BD; Garrigue JS
J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
[TBL] [Abstract][Full Text] [Related]
29. High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.
Yu X; Zhang R; Lei L; Song Q; Li X
Int J Nanomedicine; 2019; 14():591-603. PubMed ID: 30666116
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases.
Yang C; Jiang L; Bu S; Zhang L; Xie X; Zeng Q; Zhu D; Zheng Y
J Biomed Nanotechnol; 2013 Sep; 9(9):1617-23. PubMed ID: 23980509
[TBL] [Abstract][Full Text] [Related]
31. Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
Papangkorn K; Higuchi JW; Brar B; Higuchi WI
J Ocul Pharmacol Ther; 2018 May; 34(4):325-334. PubMed ID: 29432054
[TBL] [Abstract][Full Text] [Related]
32. Long-acting acid-sensitive ketal-linked dexamethasone microcrystals for treating experimental autoimmune uveitis.
Cai M; Xu Z; Zhou X; Li L; Hua X; Guo S; Yuan X
APL Bioeng; 2022 Dec; 6(4):046101. PubMed ID: 36313265
[TBL] [Abstract][Full Text] [Related]
33. Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis.
de Kozak Y; Andrieux K; Villarroya H; Klein C; Thillaye-Goldenberg B; Naud MC; Garcia E; Couvreur P
Eur J Immunol; 2004 Dec; 34(12):3702-12. PubMed ID: 15517615
[TBL] [Abstract][Full Text] [Related]
34. Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration.
Pandit J; Sultana Y; Aqil M
Carbohydr Polym; 2021 Sep; 267():118217. PubMed ID: 34119171
[TBL] [Abstract][Full Text] [Related]
35. The in-vitro and in-vivo characterization of PLGA:L-PLA microspheres containing dexamethasone sodium phosphate.
Eroğlu H; Kaş HS; Oner L; Türkoğlu OF; Akalan N; Sargon MF; Ozer N
J Microencapsul; 2001; 18(5):603-12. PubMed ID: 11508766
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone intravitreal implant for the treatment of noninfectious uveitis.
Hunter RS; Lobo AM
Clin Ophthalmol; 2011; 5():1613-21. PubMed ID: 22140307
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
[TBL] [Abstract][Full Text] [Related]
38. Local cyclosporine therapy for experimental autoimmune uveitis in rats.
Nussenblatt RB; Dinning WJ; Fujikawa LS; Chan CC; Palestine AG
Arch Ophthalmol; 1985 Oct; 103(10):1559-62. PubMed ID: 3901986
[TBL] [Abstract][Full Text] [Related]
39. Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery.
Battiston K; Parrag I; Statham M; Louka D; Fischer H; Mackey G; Daley A; Gu F; Baldwin E; Yang B; Muirhead B; Hicks EA; Sheardown H; Kalachev L; Crean C; Edelman J; Santerre JP; Naimark W
Nat Commun; 2021 May; 12(1):2875. PubMed ID: 34001908
[TBL] [Abstract][Full Text] [Related]
40. Subretinal Transplantation of Human Amniotic Epithelial Cells in the Treatment of Autoimmune Uveitis in Rats.
Li J; Qiu C; Zhang Z; Yuan W; Ge Z; Tan B; Yang P; Liu J; Zhu X; Qiu C; Lai D; Guo L; Yu L
Cell Transplant; 2018 Oct; 27(10):1504-1514. PubMed ID: 30168350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
